Bausch & Lomb and Walgreen Sued, ReNu Contact Lens Solution Recall Didn’t Happen Soon Enough

Search

Topics

Uncategorized

Links
- FDA

Case Review Form

* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of injured person
(mm-dd-yyyy):

Name of medical device:

Please describe any problems or injuries caused by the device:

Other Info:

No Yes, I agree to the Parker & Waichman, LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker & Waichman, LLP monthly newsletter, InjuryAlert.

Archives

Latest Medical Device News

20 mEq Potassium Chloride in 5% Dextrose and 0.45% Sodium Chloride Injection, USP - Recall of one lot due to possible incorrect bar code for 5% Dextrose Injection, USP. The incorrect bar code could lead to a medication error resulting in the wrong drug being delivered to a patient if a bar code system is used to confirm the medication.
Gravity Compensating Accessory, High Pressure Range, Sterile, Single Use, by Integra NeuroSciences - Recall issued because the devices may leak cerebrospinal fluid which may cause inflammation of brain, spinal cord, or abdominal membranes, pressure on the wound created by implantation of the device, or failure of the shunt system.
Greenline-D MacIntosh No. 3 Laryngoscope Blades - Class 1 recall due to potential for piece of blade to break off during procedure.
Healon D Ophthalmic Viscosurgical Device - Recall of one lot of the product because some of the tested OVD syringes had endotoxin levels above the required limit.
Hydromorphone HCl 2 mg Tablets - Nationwide recall of a single lot due to potential for oversized tablets.
Innohep (tinzaparin sodium injection) - [UPDATE] Dear Healthcare Professional letter issued re: increased risk of death in elderly patients with renal insufficiency
October 2008 Safety Labeling Changes - Summary of safety-related revisions to the BOXED WARNING, CONTRAINDICATIONS, WARNINGS, PRECAUTIONS, and ADVERSE REACTIONS sections of drug Prescribing Information, plus Patient Package Inserts and Medication Guides.
Oral Sodium Phosphate (OSP) Products for Bowel Cleansing (marketed as Visicol and OsmoPrep, and oral sodium phosphate products available without a prescription) - Reports of acute phosphate nephropathy, a type of acute kidney injury, associated with the use of oral sodium phosphate products.
Stryker Custom Cranial Implant Kits - Class 1 recall because sterility cannot be assured.
Terumo Cardiovascular Systems Tenderflow Pediatric Arterial Cannulae - Worldwide recall involving 21 lot codes, due to reports of difficulty retracting the introducer from the cannula.
Weight Loss Pills - Products contain undeclared, active pharmaceutical ingredients that may put consumers' health at risk.

Bausch & Lomb and Walgreen Sued, ReNu Contact Lens Solution Recall Didn’t Happen Soon Enough

November 7th, 2007 amy

Bausch & Lomb, Inc. and Walgreen Co. are being sued by a Chicago woman who claims using the recalled contact lens solution ReNu with MoistureLoc caused an eye infection requiring medical treatment.

The plaintiff in this St. Clair County Circuit Court case claims she went through antibiotic and steroid treatment as a result of using this product and is now at risk for further injury, corneal surgery or even vision loss, without the proper treatment.

Bausch & Lomb recalled ReNu with MoistureLoc contact lens solution in 2006. The defective product is linked to Fusarium Keratitis, a rare eye infection that can cause blindness. Bausch & Lomb pulled the product from Asian markets in February 2006 and U.S. markets in April. A worldwide recall was issued in May.

According to court documents in the St. Clair County case, by May 18, 2006 the Centers for Disease Control (CDC) had already received reports of 130 confirmed cases of Fusarium Keratitis infection reported from 26 states and one territory. Because of these infections, corneal transplantation was required in 37 of those confirmed cases. Among the 130 patients with confirmed cases, 75 reported using Bausch & Lomb’s ReNu alone and 14 reported using ReNu in combination with other products.

In October, the Food and Drug Administration (FDA) issued a warning to Bausch & Lomb criticizing them for not reporting nearly three dozen infections linked to use of this product occurring before the suspension of product sales.

This St. Clair County case is only one of many potential product liability lawsuits Bausch & Lomb will face because of this contact lens solution. Analysts predict a loss of $1 billion or more for product liability claims.

Share and Enjoy: These icons link to social bookmarking sites where readers can share and discover new web pages.